泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03347 泰格医药

休市中 02-06 16:08:04

54.000

+1.000

+1.89%

最高54.150	最低51.400	成交量229.61万
今开52.250	昨收53.000	日振幅5.19%
总市值464.94亿	流通市值66.49亿	总股本8.61亿
成交额1.22亿	换手率1.86%	流通股本1.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":54,"timestamp":1770365284008,"preClose":53,"halted":0,"volume":2296116,"delay":0,"changeRate":0.018867924528301886,"floatShares":123124800,"shares":861000000,"eps":0.5290107260857335,"marketStatus":"休市中","change":1,"latestTime":"02-06 16:08:04","open":52.25,"high":54.15,"low":51.4,"amount":122113603,"amplitude":0.051887,"askPrice":54.05,"askSize":1500,"bidPrice":54,"bidSize":44300,"shortable":3,"etf":0,"ttmEps":0.8047902064417323,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":7,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":53,"dividendRate":0.006254,"openAndCloseTimeList":[[1770341400000,1770350400000],[1770354000000,1770364800000]],"volumeRatio":0.7739262063354075,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":65.65,"timestamp":1770361200000,"preClose":63.7,"halted":0,"volume":17501200,"delay":0,"premium":"-27.01"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2609651585","title":"泰格医药新注册《泰格医药支撑远程监查系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609651585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609651585?lang=zh_cn&edition=full","pubTime":"2026-02-07 02:13","pubTimestamp":1770401591,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰格医药（300347）新注册了《泰格医药支撑远程监查系统V1.0》项目的软件著作权。今年以来泰格医药新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.27亿元，同比增1.85%。通过天眼查大数据分析，杭州泰格医药科技股份有限公司共对外投资了59家企业，参与招投标项目53次；财产线索方面有商标信息79条，专利信息17条，著作权信息177条；此外企业还拥有行政许可45个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020700000210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","LU1820825898.SGD","300347","BK1141","BK1576","BK0216","LU1146622755.USD","BK0174","03347","BK0077","BK1583"],"gpt_icon":0},{"id":"2609207550","title":"医药生物行业双周报：第十一批国采中选结果加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2609207550","media":"东莞证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609207550?lang=zh_cn&edition=full","pubTime":"2026-02-06 00:00","pubTimestamp":1770307200,"startTime":"0","endTime":"0","summary":"SW医药生物行业跑输同期沪深300指数。第十一批国采中选结果明确于2月落地实施。各地关于第十一批国采中选结果资质申报、落地执行工作等通知集中发布于1月27日-2月4日，上海率先启动，随后浙江、陕西、安徽等地跟进，逐渐覆盖全国多个地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206145618a4836857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206145618a4836857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2609587412","title":"每日卖空追踪 | 泰格医药 02月05日卖空量成交15.4万股，卖空比例为10.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609587412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609587412?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:30","pubTimestamp":1770280234,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月05日，跌0.75%，卖空量成交15.4万股，较上一交易日减少55.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163652a47f6328&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163652a47f6328&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1576","03347"],"gpt_icon":0},{"id":"2608143360","title":"季度业绩前瞻 | 泰格医药：预测全年营业收入70.65~77.06亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608143360","media":"朝阳永续","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608143360?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:55","pubTimestamp":1770206148,"startTime":"0","endTime":"0","summary":"1.  泰格医药 全年业绩预期怎么样？截至2026年02月04日，根据朝阳永续季度业绩前瞻数据：预测营业收入70.65~77.06亿元；预测净利润9.25~15.49亿元。关注后续财报数据披露后能否超预期，朝阳永续A股季度业绩前瞻数据将为投资者提供业绩鉴定。（注：本文内容基于朝阳永续AI技术生成，文中相关盈利预测数据均来自朝阳永续盈利预测数据库）风险提示：本文所示数据或案例仅供参考之用，不能作为未来投资依据。投资股票有风险，市场波动、公司业绩、政策因素等都可能导致股票价格波动。请您在投资前充分了解相关信息，并根据自身的风险承受能力做出投资决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204200130a6d2c7c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204200130a6d2c7c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347"],"gpt_icon":0},{"id":"2608196360","title":"每日卖空追踪 | 泰格医药 02月04日卖空量成交15.22万股，卖空比例为9.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608196360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608196360?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193833,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月04日，涨2.01%，卖空量成交15.22万股，较上一交易日减少68.51%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163739a47b102c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163739a47b102c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03347","BK1141","BK1583"],"gpt_icon":0},{"id":"2608360159","title":"泰格医药02月04日主力净流入400.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608360159","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608360159?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192949,"startTime":"0","endTime":"0","summary":"02月04日, 泰格医药股价涨2.01%，报收53.40元，成交金额8870.6万元，换手率1.36%，振幅7.83%，量比0.50。泰格医药今日主力资金净流入400.0万元，上一交易日主力净流出225.0万元。该股近5个交易日上涨11.66%，主力资金累计净流入1254.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4944.3万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162054a47afdee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162054a47afdee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","03347","BK1583","BK1141"],"gpt_icon":0},{"id":"1115951937","title":"杭州泰格医药（03347、300347）更新2026年1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1115951937","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115951937?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:36","pubTimestamp":1770107796,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年2月3日公布了截至2026年1月31日的股份变动月报表，报告显示公司股本状况整体保持稳定。公司注册股本方面，A股注册股数为737,901,250股，H股注册股数为123,124,800股，两者在本月均无增减，总注册股本维持在861,026,050股。已发行股份和库存股数量同样未发生变动，其中A股已发行732,017,470股，另有5,883,780股A股作为库存股；H股已发行123,124,800股，无库存股。公司表示，未来将严格遵守香港联交所《上市规则》以及相关法律法规的规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"gpt_icon":0},{"id":"2608867266","title":"泰格医药（300347）披露关于变更公司注册地址及修订公司章程的公告，2月2日股价下跌4.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608867266","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608867266?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:29","pubTimestamp":1770042559,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，泰格医药报收于60.21元，较前一交易日下跌4.44%，最新总市值为518.42亿元。近日，杭州泰格医药科技股份有限公司发布《关于变更公司注册地址及修订公司章程的公告》。公告显示，公司于2026年2月2日召开第五届董事会第二十一次会议，审议通过《关于变更公司注册地址及修订<公司章程>的议案》。董事会提请股东大会授权办理相关工商变更登记手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1583","BK0077","300347","LU1820825898.SGD","BK0216","03347","BK0028","BK0174","BK1141","LU1146622755.USD"],"gpt_icon":0},{"id":"2608607688","title":"泰格医药：控股子公司为控股孙公司方达苏州提供不超过300万元担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607688","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607688?lang=zh_cn&edition=full","pubTime":"2026-02-02 18:35","pubTimestamp":1770028521,"startTime":"0","endTime":"0","summary":"泰格医药 公告，公司控股子公司方达上海拟为控股孙公司方达苏州向 江苏银行 苏州分行申请不超过300万元的授信业务提供连带责任保证。截至公告日，方达苏州的担保余额为300万元，本次担保旨在满足其日常业务发展需要，风险可控，符合公司利益。公司累计对合并报表范围外主体担保余额为0元，无逾期担保情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202183854a47305d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202183854a47305d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","03347","BK1583","BK1576"],"gpt_icon":0},{"id":"2608586079","title":"每日卖空追踪 | 泰格医药 02月02日卖空量成交21.54万股，卖空比例为7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608586079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608586079?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021034,"startTime":"0","endTime":"0","summary":"泰格医药北京时间02月02日，跌8.06%，卖空量成交21.54万股，较上一交易日减少80.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163750a6c986ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163750a6c986ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","03347","BK1576"],"gpt_icon":0},{"id":"2608607918","title":"泰格医药营收恢复增长趋势，净新签订单维持较好增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2608607918","media":"中信建投","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608607918?lang=zh_cn&edition=full","pubTime":"2026-02-02 13:16","pubTimestamp":1770009367,"startTime":"0","endTime":"0","summary":"简评全年营收恢复增长，业绩符合预期25年公司预计实现营业收入为66.6-76.8亿元，同比增长1%-16%。归母净净利润同比大幅增长，主要由于公司其他非流动金融资产的投资收益和公允价值变动收益较大所致。净新签订单维持较好增长，订单价格已经企稳2025年受益于中国创新药研发产业链持续火热，临床C RO行业需求延续复苏趋势。但公司顺应国内外临床研究需求复苏趋势，持续加强订单引入及转化，全年净新签订单保持良好增长，25年收入恢复增长趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202133834a471e678&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202133834a471e678&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347"],"gpt_icon":0},{"id":"2608781860","title":"医药生物行业2025年报业绩前瞻：关注结构性机会 业绩增长主线聚焦CXO、创新药与高值耗材","url":"https://stock-news.laohu8.com/highlight/detail?id=2608781860","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608781860?lang=zh_cn&edition=full","pubTime":"2026-02-02 00:00","pubTimestamp":1769961600,"startTime":"0","endTime":"0","summary":"业绩预告发布情况：截止至2 月1 日A 股共有261 家医药上市公司发布2025 年报业绩预告。此外，2025 年度仍有132 家公司归母净利润为亏损，其中包括36 家首次出现亏损。业绩增长主线聚焦CXO、创新药与高值耗材。从细分板块来看，CXO、创新药与高值耗材板块中有多家公司在2025 年实现了显著增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202193157a6ca27bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202193157a6ca27bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","06978","BK1574","BK1141","BK1576","BK1161","BK1583"],"gpt_icon":0},{"id":"2607090920","title":"1月30日泰格医药涨6.96%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090920","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607090920?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:42","pubTimestamp":1769762528,"startTime":"0","endTime":"0","summary":"证券之星消息，1月30日泰格医药涨6.96%创60日新高，收盘报63.01元，换手率4.07%，成交量23.05万手，成交额14.75亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共96家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为138.43亿元，最新净值1.799，较上一交易日上涨0.56%，近一年上涨19.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","BK0077","BK0174","LU1820825898.SGD","BK1141","BK0216","03347","BK1576","159760","BK0028","LU1146622755.USD","BK1583"],"gpt_icon":0},{"id":"2608507077","title":"瑞银：泰格医药(03347)去年纯利逊预期 关注今年新签订单价格复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2608507077","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608507077?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:56","pubTimestamp":1769759765,"startTime":"0","endTime":"0","summary":"现予泰格医药(03347)目标价57.1港元及“买入”评级。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260130/20260130155838_52529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260130/20260130155838_52529.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300347","LU1820825898.SGD","BK1141","BK1583","BK1576","LU1146622755.USD","BK0077","BK0028","BK0216","03347","BK0174"],"gpt_icon":0},{"id":"2607094725","title":"大摩：看好泰格医药(03347)新订单增长强劲 集团管理层对行业前景保持乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=2607094725","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607094725?lang=zh_cn&edition=full","pubTime":"2026-01-30 15:34","pubTimestamp":1769758474,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，泰格医药公布2025年初步业绩，营收介乎为66.6亿元至76.8亿元人民币(下同)，同比增长1%至16%。该范围较摩根士丹利预估为低2%至高12%。予泰格医药A股目标价81元，评级“增持”。摩根士丹利表示，强劲的盈利增长主要归因于泰格医药资产的大幅重估，以及2024年相对较低的基数。大摩又指，集团管理层对行业前景保持乐观，而近期的一次会议上，管理层提到中国CRO行业似乎正处于复苏态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","BK0077","BK0174","LU1820825898.SGD","BK1141","BK0216","03347","BK1576","BK0028","LU1146622755.USD","BK1583"],"gpt_icon":0},{"id":"2607023082","title":"业绩喜忧参半！泰格医药A、H股双双大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2607023082","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607023082?lang=zh_cn&edition=full","pubTime":"2026-01-30 14:11","pubTimestamp":1769753499,"startTime":"0","endTime":"0","summary":"1月30日，二级市场反应热烈，泰格医药A、H股双双走强。经过一系列努力，泰格医药的新签订单数量和金额同比均有所增加。对于2025年利润的变化，泰格医药称，公司归母净利润同比大增，主要源于非经常性损益的爆发。该行建议关注，泰格医药2026年新签订单的价格复苏讯号，以及管理层对2026年收入及利润的指引。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130141408a6bebe27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130141408a6bebe27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1141","BK1583","03347"],"gpt_icon":0},{"id":"2607093352","title":"高盛：升泰格医药(03347)目标价至66.4港元 预计订单势头将复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2607093352","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607093352?lang=zh_cn&edition=full","pubTime":"2026-01-30 13:40","pubTimestamp":1769751635,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，高盛发布研报称，将泰格医药2025至2027年盈利预测分别下调29%、上调2%及上调2%，将泰格医药H股目标价由63.4港元微升至66.4港元，泰格医药A股 目标价由78.7元人民币升至82.5元人民币，均予“买入”评级。泰格医药公布盈利预告，预计2025年收入介乎66.6亿至76.8亿元人民币(下同)，较该行及市场预期高。经常性净利润介乎3.3亿至4.9亿元，则逊该行及市场预期，主要由于减值拨备高于预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300347","03347"],"gpt_icon":0},{"id":"1142349442","title":"杭州泰格医药2025年度营收66.6亿元至76.8亿元，净利润3.3亿元至4.9亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142349442","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142349442?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:41","pubTimestamp":1769690482,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司披露的2025年度业绩预告显示，营收预计为人民币666,000万元至人民币768,000万元，同比增长1%至16%。扣除非经常性损益后的净利润预计为人民币33,000万元至人民币49,000万元，较上年同期的人民币85,489.54万元下降43%至61%。公司经营活动产生的现金流量净额约为人民币110,000万元至人民币130,000万元，同比增加人民币299.81万元至人民币20,299.81万元，体现了一定程度的正向增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"gpt_icon":0},{"id":"2607704786","title":"泰格医药：2025年净利同比预增105%~204%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607704786","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607704786?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:54","pubTimestamp":1769676883,"startTime":"0","endTime":"0","summary":"每经AI快讯，1月29日，泰格医药(300347.SZ)公告称，预计2025年归属于上市公司股东的净利润为8.30亿元~12.30亿元，比上年同期增长105%~204%。业绩变动主要系报告期内非经常性损益大幅增加，公司持有的非流动金融资产（包括非上市公司股权、上市公司股份及医药基金）处置及持有收益显著提升，叠加中国创新药行业复苏带动资产价值修复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601293635289384.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601293635289384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK1583","BK0077","BK0028","300347","LU1146622755.USD","LU1820825898.SGD","03347","BK0174","BK1141","BK1576"],"gpt_icon":0},{"id":"2607649960","title":"每日卖空追踪 | 泰格医药 01月29日卖空量成交10.7万股，卖空比例为3.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607649960","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607649960?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675435,"startTime":"0","endTime":"0","summary":"泰格医药北京时间01月29日，涨6.74%，卖空量成交10.7万股，较上一交易日增加271.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164126a6bae4cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164126a6bae4cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1576","BK1583","BK1141"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":0.0693},{"period":"3month","weight":0.2688},{"period":"6month","weight":0.0256},{"period":"1year","weight":0.9001},{"period":"ytd","weight":0.2694}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家从事为新药研发提供临床试验服务的中国控股公司。该公司经营两个分部。临床试验技术服务分部向生物制药和医疗器械公司提供临床试验运作服务和医学翻译等服务，帮助其进行创新药物、仿制药和医疗器械的临床试验。临床试验相关服务及实验室服务分部从事提供分析服务，比如数据管理和统计分析；后勤和执行支持服务，比如临床试验现场管理；行政协助，比如患者招募；以及咨询服务等。该分部同时通过其子公司为临床前和临床开发阶段提供实验室服务。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.03226},{"month":2,"riseRate":0.5,"avgChangeRate":0.02436},{"month":3,"riseRate":0.6,"avgChangeRate":-0.015344},{"month":4,"riseRate":0.2,"avgChangeRate":-0.055126},{"month":5,"riseRate":0.4,"avgChangeRate":0.024418},{"month":6,"riseRate":0.6,"avgChangeRate":0.024718},{"month":7,"riseRate":0.6,"avgChangeRate":0.079529},{"month":8,"riseRate":0,"avgChangeRate":-0.091864},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032065},{"month":10,"riseRate":0.5,"avgChangeRate":-0.02594},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001375},{"month":12,"riseRate":0.5,"avgChangeRate":0.041249}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}